STOCK TITAN

Polyrizon (PLRZ) director sells 3,292 shares, retains 19,850 total

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Polyrizon Ltd. director Adler Oz reported an open-market sale of 3,292 Ordinary Shares on March 31, 2026 at a weighted average price of $12.05 per share, with individual trade prices ranging from $12.00 to $12.1041.

After this transaction, Oz holds a total of 19,850 Ordinary and restricted Ordinary Shares, consisting of 3,363 Ordinary Shares, 29 restricted Ordinary Shares that vest monthly, and 16,458 restricted Ordinary Shares that vest quarterly, all subject to continued service.

Positive

  • None.

Negative

  • None.
Insider Adler Oz
Role Director
Sold 3,292 shs ($40K)
Type Security Shares Price Value
Sale Ordinary Shares 3,292 $12.05 $40K
Holdings After Transaction: Ordinary Shares — 19,850 shares (Direct)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.1041, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Consists of (1) 3,363 ordinary shares, (2) 29 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (3) 16,458 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.
Shares sold 3,292 shares Open-market sale on March 31, 2026
Weighted average sale price $12.05 per share Ordinary Shares sold in multiple transactions
Sale price range $12.00–$12.1041 per share Range of prices for individual trade executions
Total holdings after transaction 19,850 shares Ordinary and restricted Ordinary Shares after sale
Ordinary Shares held 3,363 shares Portion of total holdings after transaction
Monthly-vesting restricted shares 29 shares Restricted Ordinary Shares vesting in equal monthly installments
Quarterly-vesting restricted shares 16,458 shares Restricted Ordinary Shares vesting in equal quarterly installments
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted ordinary shares financial
"Consists of (1) 3,363 ordinary shares, (2) 29 restricted ordinary shares..."
Restricted ordinary shares are common stock that cannot be sold or transferred until certain conditions are met—such as a time period passing, performance targets being reached, or regulatory approvals—often issued to employees, founders, or early investors. They matter because those restrictions delay when the shares can enter the market, affecting the future supply of shares, potential dilution and company valuation; think of them as goods locked in a warehouse until release conditions are satisfied.
vest in equal installments financial
"restricted ordinary shares that vest in equal installments on a monthly basis..."
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Adler Oz

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares03/31/2026S3,292D$12.05(1)19,850(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.1041, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. Consists of (1) 3,363 ordinary shares, (2) 29 restricted ordinary shares that vest in equal installments on a monthly basis, subject to the Reporting Person's continued service, and (3) 16,458 restricted ordinary shares that vest in equal installments on a quarterly basis, subject to the Reporting Person's continued service.
/s/ Oz Adler04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Adler Oz report for Polyrizon (PLRZ)?

Adler Oz reported selling 3,292 Polyrizon Ordinary Shares in an open-market transaction. The weighted average sale price was $12.05 per share, with individual trades executed between $12.00 and $12.1041, according to the Form 4 disclosure and its detailed pricing footnote.

What price did Adler Oz receive for the 3,292 Polyrizon (PLRZ) shares sold?

The reported weighted average sale price was $12.05 per Polyrizon Ordinary Share. A footnote explains these shares were sold through multiple trades at prices ranging from $12.00 to $12.1041, and detailed trade-by-trade information is available upon request from the reporting person.

How many Polyrizon (PLRZ) shares does Adler Oz own after this Form 4 sale?

Following the reported sale, Adler Oz holds 19,850 Polyrizon Ordinary and restricted Ordinary Shares. This total includes 3,363 Ordinary Shares, 29 restricted shares vesting monthly, and 16,458 restricted shares vesting quarterly, all contingent on his continued service to the company.

What types of Polyrizon (PLRZ) equity awards are included in Adler Oz’s holdings?

Adler Oz’s reported holdings include standard Ordinary Shares and restricted Ordinary Shares. The restricted portion consists of 29 shares that vest in equal monthly installments and 16,458 shares that vest in equal quarterly installments, each subject to his continued service with Polyrizon.

Is the Polyrizon (PLRZ) Form 4 sale by Adler Oz a market transaction?

Yes. The Form 4 describes the transaction as an open-market sale of Ordinary Shares. The shares were sold in multiple trades on the market, and the filing reports a weighted average sale price along with the range of individual execution prices during the trading activity.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

18.95M
1.61M
Biotechnology
Healthcare
Link
Israel
Ra'anana